Johnson & Johnson presents new IMAAVY® data at European Academy of Neurology 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis Pharmaceutical Investing
Cumberland Pharmaceuticals Shares Updated FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference Life Science Investing
Medexus Announces Fiscal Year 2026 Results, Demonstrating Continued Momentum and Strong Product-Level Performance of GRAFAPEX for Injection Pharmaceutical Investing
The Aesthetics Giants Just Confirmed "Ozempic Face" Is Real - and a Newly Public Regenerative Player Wants to Compete for It Pharmaceutical Investing
BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT Pharmaceutical Investing
Exo-Top, NurExone's wholly owned U.S. Subsidiary, Enters Into Binding MOU For Naïve Exosome Distribution in Mexico Life Science Investing
U.S. FDA Approves Trodelvy® for First-Line Treatment of Metastatic Triple-Negative Breast Cancer Life Science Investing
